Deep learning is an important element of AI that’s helping advance diagnostics and treatment, but it also remains relatively uncharted territory.

A collaboration between Boston-based pharmaceutical startup Berg and French company Sanofi could one day result in more precise flu vaccines and even personalized shots tailored to individuals’ unique immune systems, Time reported March 5.

Though the idea of artificial intelligence displacing radiologists worries more than half of surveyed medical students interested in an imaging career, radiology programs have seen a spike in applications in recent years, according to work published in Academic Radiology.

A recently discovered property of spider silk known as supercontraction could one day comprise a key building block of artificial muscles and robotic actuators, according to research published March 1 in Science Advances.

A report released by Portland-based firm Big Market Research on March 6 projects the artificial intelligence in medicine market will grow to $18.12 billion by 2025, advancing at a compound annual growth rate (CAGR) of 49.6 percent.

AI systems can detect breast cancer just as well as radiologists, according to a study published March 5 in the Journal of the National Cancer Institute.

Amazon has extended a grant valued at $2 million to Harvard Medical School so the medical giant can experiment with machine learning and AI to streamline their clinical workflow, Bloomberg reported March 4.

FDA Commissioner Scott Gottlieb is resigning. Gottlieb has manned the agency since May 2017 and will leave his position in about a month.

Researchers from the Icahn School of Medicine at Mount Sinai have developed an AI platform that’s reportedly capable of detecting a range of neurodegenerative diseases in human brain tissue samples, according to a study published in the February issue of Laboratory Investigation.

Forty percent of so-called AI startups in Europe don’t actually use AI programs in their products, the Financial Times reported March 4.